Velká Británie -
angličtina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
gabup 6mg sublingual tablets
martindale pharmaceuticals ltd - buprenorphine hydrochloride - sublingual tablet - 6mg
Velká Británie -
angličtina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
buprenorphine 8mg sublingual tablets sugar free
thornton & ross ltd - buprenorphine hydrochloride - sublingual tablet - 8mg
Velká Británie -
angličtina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
buprenorphine 2mg sublingual tablets sugar free
thornton & ross ltd - buprenorphine hydrochloride - sublingual tablet - 2mg
Velká Británie -
angličtina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
buprenorphine 8mg sublingual tablets sugar free
sigma pharmaceuticals plc - buprenorphine hydrochloride - sublingual tablet - 8mg
Velká Británie -
angličtina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
buprenorphine 2mg sublingual tablets sugar free
viatris uk healthcare ltd - buprenorphine hydrochloride - sublingual tablet - 2mg
Velká Británie -
angličtina -
MHRA (Medicines & Healthcare Products Regulatory Agency)
buprenorphine 8mg sublingual tablets sugar free
viatris uk healthcare ltd - buprenorphine hydrochloride - sublingual tablet - 8mg
Malta -
angličtina -
Medicines Authority
buprenorphine 2mg sublingual tablets / natzon 2mg sublingual tablets
morningside healthcare limited - buprenorphine hydrochloride - sublingual tablet - buprenorphine hydrochloride 2 mg - other nervous system drugs
Malta -
angličtina -
Medicines Authority
buprenorphine 8mg sublingual tablets / natzon 8mg sublingual tablets
morningside healthcare limited - buprenorphine hydrochloride - sublingual tablet - buprenorphine hydrochloride 8 mg - other nervous system drugs
Kanada -
angličtina -
Health Canada
probuphine implant
knight therapeutics inc. - buprenorphine hydrochloride - implant - 80mg - buprenorphine hydrochloride 80mg - opiate partial agonists
Evropská unie -
angličtina -
EMA (European Medicines Agency)
buvidal
camurus ab - buprenorphine - opioid-related disorders - other nervous system drugs - treatment of opioid dependence within a framework of medical, social and psychological treatment. treatment is intended for use in adults and adolescents aged 16 years or over.